Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-102966
Filing Date
2025-08-05
Accepted
2025-08-05 16:01:03
Documents
52
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrus-20250630.htm   iXBRL 10-Q 3755005
2 EX-31.1 mrus-ex31_1.htm EX-31.1 17651
3 EX-31.2 mrus-ex31_2.htm EX-31.2 17291
4 EX-32.1 mrus-ex32_1.htm EX-32.1 15214
  Complete submission text file 0000950170-25-102966.txt   14294659

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mrus-20250630.xsd EX-101.SCH 956454
55 EXTRACTED XBRL INSTANCE DOCUMENT mrus-20250630_htm.xml XML 3900990
Mailing Address YALELAAN 62 3584 CM UTRECHT DE
Business Address YALELAAN 62 3584 CM UTRECHT DE 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37773 | Film No.: 251184720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)